Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

COVID-19 booster programme

- PMLiVE

CEPI says $2bn is needed for COVID-19 vaccine development

Funding will be used to take candidates through all stages of development

- PMLiVE

Did Trump offer CureVac $1bn for COVID-19 vaccine rights?

Media reports claim Trump administration tried to secure exclusive rights

- PMLiVE

Lilly and AbCellera partner on antibody therapies for COVID-19

Latest companies to join the fight against the novel coronavirus

Roche Basel Switzerland

FDA okays Roche’s COVID-19 diagnostic test

Increases capacity for testing as coronavirus cases grow

- PMLiVE

UK officially moves into ‘delay’ phase of coronavirus plan

New measures includes broader self-isolation advice

- PMLiVE

Potential universal flu vaccine shows efficacy in clinical trial

Candidate will now move forward into late-stage testing

- PMLiVE

WHO labels coronavirus outbreak a pandemic as cases spread globally

WHO director-general maintains countries can still "change the course" of the outbreak

AstraZeneca AZ

AZ’s comeback drug cediranib stumbles in phase 3 trial

Failed to improve on platinum-based chemotherapy

- PMLiVE

Gates Foundation, Wellcome launch fast-track COVID-19 therapy fund

Partners commit $125m to seed-fund for potential treatments

- PMLiVE

NHS increases COVID-19 testing capacity, FDA halts foreign inspections

New measures to tackle the novel coronavirus announced across the Atlantic

EU flag

EMA to consider coronavirus’ impact on EU medicines supply

Steering group will identify EU-wide actions to mitigate medicine supply risks

- PMLiVE

US Department of Health and Human Services calls for coronavirus product proposals

Move will fast-track the development of potential treatments

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links